Artios Pharma
Phase 2Artios is a leading independent DDR Company with a strong pipeline of novel cancer therapies in development with first-in-class & best-in-class potential.
Founded
2016
Focus
Small Molecules
About
Artios is a leading independent DDR Company with a strong pipeline of novel cancer therapies in development with first-in-class & best-in-class potential.
Funding History
3Total raised: $270M
Series C$153MOmega FundsNov 15, 2020
Series B$84MAndera PartnersJul 15, 2018
Series A$33MSV Health InvestorsOct 15, 2016
Company Info
TypePrivate
Founded2016
LocationCambridge, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile